APA Citatie

Su, P., Yang, S., Chen, Y., Wu, Y., Lin, C., Chang, W., . . . Su, W. (2019). Real‐world outcomes of NSCLC patients receiving tissue or circulating tumor DNA‐guided osimertinib treatment. Cancer Med.

Chicago Style citaat

Su, Po‐Lan, et al. "Real‐world Outcomes of NSCLC Patients Receiving Tissue or Circulating Tumor DNA‐guided Osimertinib Treatment." Cancer Med 2019.

MLA citatie

Su, Po‐Lan, et al. "Real‐world Outcomes of NSCLC Patients Receiving Tissue or Circulating Tumor DNA‐guided Osimertinib Treatment." Cancer Med 2019.

Let op: Deze citaties zijn niet altijd 100% accuraat.